Pure Global

Clinical Trial - Trial ChiCTR2200055418

Access comprehensive clinical trial information for ChiCTR2200055418 through Pure Global AI's free database. This Phase 1 trial is sponsored by Dongzhimen Hospital, Beijing University of Chinese Medicine and is currently Recruiting. The study focuses on Hepatitis B.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
ChiCTR2200055418
Phase 1
Recruiting
Trial Details
Chinese Clinical Trial Registry • ChiCTR2200055418
View on Chinese Clinical Trial Registry
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Untitled Trial
Analysis of viral transcriptional activity of chronic hepatitis B in different HBeAg infection states and prediction of drug withdrawal safety

Study Focus

Hepatitis B

Sponsor & Location

Dongzhimen Hospital, Beijing University of Chinese Medicine

Special funds for basic scientific research business expenses of central colleges and universities of Beijing University of Traditional Chinese Medicine

China

Timeline & Enrollment

Phase 1

N/A

Dec 31, 2022

ICD-10 Classifications

Acute hepatitis B
Acute hepatitis B without delta-agent and without hepatic coma
Acute delta-(super)infection in chronic hepatitis B
Chronic viral hepatitis B without delta-agent
Chronic viral hepatitis B without delta-agent : other and unspecified phase

Data Source

Chinese Clinical Trial Registry

ChiCTR2200055418

Non-Device Trial